Michael Ellenbogen - 21 Sep 2022 Form 4 Insider Report for Evolv Technologies Holdings, Inc. (EVLV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Sep 2022, 16:27:50 UTC
Prior SEC filing
15 Sep 2022
Next SEC filing
04 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Pyenson, Attorney-in-fact for Michael Ellenbogen

Key filing fact

Michael Ellenbogen filed Form 4 for Evolv Technologies Holdings, Inc. (EVLV) on 23 Sep 2022.

Key facts

  • This page summarizes Michael Ellenbogen's Form 4 filing for Evolv Technologies Holdings, Inc. (EVLV).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Sep 2022, 16:27.

Change

  • Previous filing in this sequence was filed on 15 Sep 2022.
  • Current net transaction value: -$317.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVLV transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+500
Change %
+0.02%
Price
Shares after
2,857,488
Date
21 Sep 2022
Ownership
Direct
Footnotes
F1
EVLV transaction

Class A Common Stock

Sale

Transaction value
$317
Shares
-151
Change %
-0.01%
Price
$2.10
Shares after
2,857,337
Date
22 Sep 2022
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVLV transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-500
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 Sep 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
500
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.

Footnote F2

The sale reported in the Form 4 was effected pursuant to a standing Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .